• Product NameEdaravone
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityEdaravone(MCI-186), a strong novel free radical scavenger, is used for treatment of patients with acute brain infarction.
• Target NameFree radical scavengers antagonist
• CAS No. 89-25-8
• Calculated MW 174.2
• Formulation C10H10N2O
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:CC1=NN(C(=O)C1)C1=CC=CC=C1
  Pathways:oxidation-reduction
  Receptor:Free radical scavengers
  Boling pt:287C
  Melting pt:126-128C
  Solubility:Ethanol: 35 mg/mL (200.91 mM); DMSO: 35 mg/mL (200.91 mM)
  Appearance:Yellow Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Yoshida H, et al. CNS Drug Rev, 2006, 12(1), 9-20.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting